GLP-s1s have been approved for use in people with type 2 diabetes since 2005-2006 in North American & Europe Weight loss, particularly when rapid, a ffects ovulation, fertility, menstrual bleeding, muscle mass, bone density, mental well-being, and cardiometabolic risk
Broccoli sprouts reduce oxidative stress in type 2 diabetes: a randomized double-blind clinical trial
Others report that previously stable hair loss worsened during therapy
Research-grade GHK-Cu sits outside the cosmetic regulatory category entirely
MASH is closely associated with metabolic syndrome and poses risks of liver-related complications, including cirrhosis and liver cancer
The low dose establishes baseline tolerance